GEHC
GE HealthCare Technologies Inc.
Stock
$64.29+0.31 (+0.48%)Close Oct 2, 2026
Income statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $21.3B | $20.6B | $19.7B | $19.6B | $18.3B | $17.6B |
| Cost of revenue | $12.9B | $12.4B | $11.5B | $11.6B | $11.2B | $10.4B |
| Gross profit | $8.4B | $8.2B | $8.2B | $7.9B | $7.2B | $7.2B |
| R&D | $1.3B | $1.3B | $1.3B | $1.2B | $1.0B | $816M |
| SG&A | $4.4B | $4.2B | $4.3B | $4.3B | $3.6B | $3.6B |
| Operating income | $2.7B | $2.8B | $2.6B | $2.4B | $2.5B | $2.8B |
| Non-operating income | −$72M | $5.0M | −$44M | −$74M | −$10M | $80M |
| Pretax income | $2.7B | $2.8B | $2.6B | $2.4B | $2.5B | $2.9B |
| Taxes | $677M | $684M | $588M | $793M | $596M | $628M |
| Net income | $2.0B | $2.1B | $2.0B | $1.6B | $1.9B | $2.2B |
| Diluted EPS | $4.36 | $4.55 | $4.34 | $3.03 | $4.22 | $4.95 |
| Diluted shares | — | 458.0M | 459.0M | 458.0M | 454.0M | 454.0M |
| Revenue growth | — | +4.8% | +0.6% | +6.6% | +4.3% | — |
| Gross margin | 39.5% | 40.0% | 41.7% | 40.5% | 39.1% | 40.8% |
| Operating margin | 12.9% | 13.4% | 13.3% | 12.5% | 13.8% | 15.9% |
| Net margin | 9.3% | 10.1% | 10.1% | 8.0% | 10.4% | 12.8% |